Mr. Rav Mlait reports

CANNABIX TECHNOLOGIES ANNOUNCES DEPLOYMENT OF MARIJUANA BREATH TEST (MBT) WITH MAJOR INDUSTRIAL OPERATOR IN QUEBEC

Cannabix Technologies Inc. has deployed its marijuana breath test (MBT) products with a major industrial company operating in the heavy materials sector with significant work force and operational footprint in Quebec. The MBT is being utilized to support workplace safety programs, including postincident and reasonable-cause testing protocols. The delivery was completed through Montreal-based Alco Prevention Canada.

This deployment reflects growing interest for breath-based THC (tetrahydrocannabinol) testing solutions in heavy industry, where employers require timely and defensible indicators of recent cannabis use for safety-critical environments. Industrial operators, regulators and insurers are increasingly seeking technologies that better align with real-time impairment risk and workplace decision-making.

Stephane Maurais, general manager, Alco Prevention Canada, stated: "We are extremely proud to partner with Cannabix to advance this innovative technology in the Canadian market. As organizations increasingly seek objective, non-invasive solutions to detect recent cannabis use. The Cannabix marijuana breath test represents a significant advancement in workplace and public safety. At Alco Prevention Canada, our mission has remained unchanged for more than 37 years: to provide practical prevention tools that help save lives, reduce risk, and promote safer workplaces, roads and communities."

Workplace testing clinics face growing need for recent-use THC assessment

Industrial workplaces, particularly in sectors such as cement production, construction materials and manufacturing, present inherently higher safety risks. Employers in these sectors must balance evolving cannabis policies with strict safety, compliance and liability requirements.

Traditional testing methods, including urine and oral fluid testing, can detect cannabis exposure long after recent use effects of THC have subsided. This extended duration creates challenges for industrial employers when making time-sensitive safety decisions which can increase the risk of disputes.

As a result, industrial organizations are seeking testing solutions that:

• Provide insight into recent cannabis use relevant to safety-sensitive roles;
• Support postincident and reasonable-cause investigations;
• Reduce ambiguity associated with historical cannabis exposure;
• Enhance defensibility of workplace testing policies and outcomes.

Legacy urine and oral fluid tests can detect cannabis exposure days or weeks after use, making it difficult to provide results that meaningfully correlates with recent use. This gap creates operational, legal and reputational risks for clinics when test results are challenged by employers, employees, unions or legal counsel.

The Cannabix MBT offers employers a new non-invasive test to complement existing drug testing programs. Breath-based THC testing provides several advantages, including:

• Short detection window aligned with recent cannabis use;
• Non-invasive collection, improving subject compliance and experience with breath testing;
• Objective, lab-confirmed results using gold-standard LC-MS analysis;
• Reduced exposure to legal challenges associated with historical positives;
• By integrating breath-based testing into their programs, industrial employers can enhance safety protocols while reducing uncertainty.

Strategic and investor-focused outlook

Cannabix believes breath-based THC testing can become a valuable tool across industrial sectors, particularly for deterrence, incident response and fitness-for-duty applications. Continued deployments with major operators are expected to support broader adoption.

About Cannabix Technologies Inc.

Cannabix Technologies is a leading developer of breath-based technologies designed to enhance public safety and reduce impairment-related risks in workplaces, law enforcement and a range of different settings. The marijuana breath test (MBT) targets delta-9 THC -- the primary psychoactive compound in cannabis -- in breath, providing a practical solution for identifying recent marijuana use.

The BreathLogix unmanned alcohol screening solution supports organizations in pro-actively monitoring alcohol impairment, strengthening safety protocols and promoting responsible behaviour. By delivering innovative, non-invasive screening tools, Cannabix aims to help reduce accidents, improve decision-making, and protect organizations, individuals and the public at large.

We seek Safe Harbor.